As clinical trial evidence on conditions that disproportionately affect women continues to lag, researchers are calling for a broader approach that draws on real-world data and citizen science to close the gap. The proposal, outlined in Nature Medicine, argues that traditional randomized controlled trials alone cannot keep pace with the range of health issues that need urgent study, and that other forms of evidence generation should be considered to improve women’s health.
The commentary highlights a persistent problem: many conditions that predominantly affect women, or that manifest differently in women, remain understudied in conventional clinical research. This leaves clinicians with limited guidance for diagnosis and treatment, and patients with fewer evidence-based options. The authors contend that waiting for more trial data is not sufficient, especially when the need for answers is immediate and the existing research infrastructure is slow to adapt.
Real-world data, which includes information gathered from electronic health records, insurance claims, wearable devices, and patient registries, offers a way to study large populations in everyday settings rather than in controlled experimental conditions. Such data can reveal patterns in disease presentation, treatment response, and outcomes that are often missed in trials with narrow inclusion criteria. Citizen science, in which members of the public contribute observations or participate in research design, adds another layer by capturing experiences that may not appear in formal medical records.
The authors argue that these approaches are particularly valuable for women’s health because many relevant conditions are chronic, underfunded, or affect women across the lifespan in ways that are poorly captured by short-term trials. Conditions such as endometriosis, polycystic ovary syndrome, autoimmune diseases, and the menopausal transition have historically received less research attention, and the evidence that does exist often relies on small or unrepresentative samples. Real-world data could help fill those gaps by providing insight into how these conditions affect diverse populations over time.
Citizen science initiatives, meanwhile, can empower patients to share detailed symptom histories, treatment experiences, and quality-of-life impacts that are rarely measured in standard clinical endpoints. This kind of information can help researchers identify priorities that matter most to patients and design studies that answer questions relevant to daily life. It also creates a channel for engaging communities that have been historically excluded from medical research, including women from minority ethnic groups, older women, and those living in low-resource settings.
The commentary acknowledges that real-world data and citizen science come with their own limitations, including issues of data quality, privacy, and potential bias in who chooses to participate. However, the authors argue that these challenges can be managed with rigorous methodology, transparent reporting, and collaboration between researchers, clinicians, and patient communities. They also note that such approaches are not meant to replace clinical trials but to complement them, especially in areas where trials are impractical, unethical, or simply too slow.
The call comes at a time when interest in women’s health research is growing, but funding and infrastructure still lag behind the burden of disease. The authors suggest that funders, regulators, and academic institutions should recognize real-world evidence as a legitimate and necessary part of the research ecosystem. They also urge the scientific community to develop standards for collecting and analyzing this type of data so that findings can be trusted and acted upon.
By looking beyond the traditional trial model, the authors conclude, the field can build a more complete picture of women’s health and deliver evidence that reflects the realities of patients’ lives. The goal is not simply more research, but better research that leads to measurable improvements in diagnosis, treatment, and prevention for women everywhere.
